Insights from 2023 SABCS


 

SABCS 2023 Insights: "A Study of RGT-419B, a Next-Gen CDK4 Inhibitor, in Pts With HR+/HER2- Advanced or Metastatic BC Who Progressed on Prior CDK4/6i"

165 views
January 3, 2024
Comments 0
Login to view comments. Click here to Login